Success Metrics

Active Trials
1(33%)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Other(2)

Detailed Status

unknown2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

recruiting133%
unknown267%

Recent Activity

1 active trials
Showing 3 of 3
recruitingnot_applicable

Evaluation of Nevisense as Support Tool for the Diagnose of Keratinocyte Skin Cancer

NCT06064019
unknownnot_applicable

Clinical Utility of Electrical Impedance Spectroscopy

NCT04161742
unknown

Detection of Skin Epithelial Barrier in Patients With Allergic Skin Disorders

NCT03581747

Clinical Trials (3)

Showing 3 of 3 trials
NCT06064019Not Applicable

Evaluation of Nevisense as Support Tool for the Diagnose of Keratinocyte Skin Cancer

Recruiting
NCT04161742Not Applicable

Clinical Utility of Electrical Impedance Spectroscopy

Unknown
NCT03581747

Detection of Skin Epithelial Barrier in Patients With Allergic Skin Disorders

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3